Skip to main content
Clinical Trials/CTRI/2016/01/006527
CTRI/2016/01/006527
Completed
Phase 4

Pharmacokinetics-Pharmacodynamics relationship of vancomycin in children with suspected or proven Gram-positive bacterial infection admitted to Pediatric intensive care unit of tertiary care hospital

Seth GSMC and KEM Hospital0 sites12 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Patients admitted to PICU with suspected or proven bacterial infection
Sponsor
Seth GSMC and KEM Hospital
Enrollment
12
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 2, 2016
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Seth GSMC and KEM Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\.Voluntarily given written, signed, informed consent from legally acceptable representative and assent from patientâ??s aged \>\= 7 to 12 years before performing any screening procedures.
  • 2\.Either gender of aged 3 \- 12 years and weight of \>\= 8 kg
  • 3\.Patients with suspected or proven Gram â?? positive bacterial infection
  • 4\.Patient receiving vancomycin therapy for at least 2 days

Exclusion Criteria

  • 1\.Patients with hypersensitivity to vancomycin hydrochloride or any excipients of its formulation or other drugs
  • 2\.Participation in any investigational study within 30 days prior to screening.
  • 3\.Patients whose Creatinine clearance \<50ml/min

Outcomes

Primary Outcomes

Not specified

Similar Trials